AIDS Quest to Kill ‘Sleeping’ Virus Enlists Merck Cancer Drug

The 30-year-long search for a cure for AIDS, the world’s deadliest viral infection, may get a renewed boost from an unlikely source: a little-used Merck & Co. cancer drug.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.